<aside>
This page introduces the GOAL 3 Foundation: why it exists, what it funds, how it is governed and how to support its work. It also links to the Foundation's annual reports and the Scaling IMPALA Fund.
</aside>
<aside> <img src="/icons/drafts_green.svg" alt="/icons/drafts_green.svg" width="40px" />
</aside>
The GOAL 3 Foundation was set up in 2023 so that IMPALA also reaches hospitals that cannot afford the full cost of implementation. GOAL 3 Social Enterprise develops, sells, delivers and services IMPALA. The Foundation raises philanthropic funding for what the market does not pay for: wards in high-need hospitals, evidence generation, and catalytic projects such as entering a new country.
Many of the hospitals where IMPALA could help most work with very tight budgets, even where the system could improve outcomes and lower costs over time. Without a subsidy, access would depend on ability to pay rather than need. The Foundation usually funds the first step, the upfront cost of equipment and implementation, while hospitals or governments pay the recurring service costs. Over time, the aim is for health systems to buy and sustain IMPALA from their own budgets.
Both entities share one mission: to empower and enable health workers at places where it is needed most. They contribute in different ways:
| GOAL 3 Social Enterprise | GOAL 3 Foundation |
|---|---|
| Develops, improves, and delivers the IMPALA platform | Mobilises philanthropic funding for hospitals and regions with limited ability to pay |
| Manages product development, operations, logistics, staffing, implementation, and service contracts | Funds public-good projects, research, innovation, and access in underserved settings |
| Builds a sustainable business model so IMPALA can keep improving and scaling | Helps ensure access is based on need, not only on ability to pay |
| Works with hospitals, governments, NGOs, and implementation partners | Works with donors, foundations, and impact partners to unlock catalytic funding |
The GOAL 3 Foundation closes the financing gap that limits access to life-saving interventions such as IMPALA. It acts as a catalyst by funding initial adoption, then transitioning to co-funding and pre-financing. The end goal is local ownership: health systems procuring and sustaining these solutions independently, embedded in budgets and no longer reliant on external donations.
For why GOAL 3 works through two entities, and examples of projects the Foundation has funded, see Hybrid model explained
<aside> <img src="/icons/gradebook_green.svg" alt="/icons/gradebook_green.svg" width="40px" />
</aside>
[click here for the annual report of 2024]
[click here for the annual report of 2025]
[click here for the Foundation plans for 2026-2027]
In 2025, the Foundation raised €0.72 million and granted €1.03 million to IMPALA projects.
<aside> <img src="/icons/briefcase_green.svg" alt="/icons/briefcase_green.svg" width="40px" />
</aside>
The GOAL 3 Foundation is an independent Dutch foundation (stichting) with ANBI status (RSIN 864979976), so gifts are tax-deductible in the Netherlands. It also holds an Equivalence Determination through NGOsource, which allows US foundations to fund it as they would a US public charity.
The Foundation has its own Supervisory Board, with governance, financial, legal and clinical expertise. A representative of GOAL 3 Social Enterprise attends without a vote, so the Social Enterprise has no control over Foundation decisions. Day-to-day management sits with the Managing Director. Co-founder Jelle Schuitemaker currently leads the Foundation as interim Managing Director; a dedicated Managing Director is expected to start at the beginning of 2027.
When the Foundation funds projects delivered by the Social Enterprise, it pays only for defined outputs, at a price that excludes the commercial profit margin. For the full governance structure, funding flows and conflict-of-interest safeguards, see Governance structure & accountability
<aside>
</aside>
<aside>
</aside>
<aside>
</aside>
The Foundation's pooled fund for paediatric wards in high-need hospitals: what it pays for, which hospitals are eligible, and how funding is allocated.